Biomarkers as Key Contributors in Treating Malignant Melanoma Metastases
Melanoma is a human neurocristopathy associated with developmental defects in the neural crest-derived epidermal melanocytes. At the present time, at least three hypotheses were identified that may explain melanoma aetiology, as follows: (1) a model of linear progression from differentiated melanocy...
Saved in:
Main Authors: | Camila Ferreira de Souza, Alice Santana Morais, Miriam Galvonas Jasiulionis |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | Dermatology Research and Practice |
Online Access: | http://dx.doi.org/10.1155/2012/156068 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
miRNAs and Melanoma: How Are They Connected?
by: Adriana Taveira da Cruz, et al.
Published: (2012-01-01) -
Erratum to “Gastric and Rectal Metastases from Malignant Melanoma Presenting with Hypochromic Anemia and Treated with Immunotherapy”
by: Pietro Genova, et al.
Published: (2018-01-01) -
Bilateral Choroidal Metastases as Presentation of Dissemination of Cutaneous Malignant Melanoma
by: S. Fernandez-Perez, et al.
Published: (2012-01-01) -
MELANOMAS, SARCOMAS, AND RENAL METASTASES IN THE LIVER: HOW TO TREAT?
by: Angelica Maria LUCCHESE, et al.
Published: (2025-01-01) -
Prognostic value of immune biomarkers in melanoma loco-regional metastases.
by: Emilia Hugdahl, et al.
Published: (2025-01-01)